By John Ericson | Mon, 12/02/2013 - 14:48
David Kwiatkowski, a traveling hospital technician who infected at least 32 people with hepatitis C using syringes tainted with his own infected blood, will receive his sentence on Monday.
By Anthony Rivas | Tue, 11/05/2013 - 20:35
A double-drug combination pill was able to cure 95 percent of hepatitis C patients, regardless of how they responded to currently available treatments.
By Lecia Bushak | Sat, 11/02/2013 - 14:43
A combination of two oral hepatitis C drugs manufactured by Merck lead to high cure rates and less side effects in a clinical trial, prompting some patients to wait for it to come to market.
By Anthony Rivas | Tue, 10/29/2013 - 20:32
In one mother, the processes that occurred during pregnancy combined with the natural viral processes of hepatitis C to help create a strain that was able to replicate faster.
By Lecia Bushak | Fri, 10/25/2013 - 18:48
The doctor who infected nine patients with Hepatitis C is guilty of 27 charges and has received a life sentence.
By Anthony Rivas | Wed, 10/23/2013 - 16:31
A new wave of hepatitis C drugs could improve the cure rate for the scores of people who don't respond well to current treatments.
By Nsikan Akpan | Tue, 08/27/2013 - 14:51
The hepatitis C virus was stopped in hard-to-treat patients with the experimental combination of sofosbuvir and ribavirin.
By Nadia-Elysse Harris | Tue, 08/13/2013 - 09:55
David Kwiatkowski, a traveling hospital technician, is set to plead guilty Tuesday for infecting at least 32 people with hepatitis C using syringes tainted with his own infected blood.
By Jonathan Weiss | Tue, 06/25/2013 - 13:38
The US Preventive Services Task Force has issued guidelines encouraging baby boomers to be tested for hepatitis C.
By Jonathan Weiss | Thu, 06/20/2013 - 14:25
The newly FDA-approved hepatitis C genotyping test comes months before the FDA is set to announce approvals of new drugs for certain genotypes of the virus.
By Jonathan Weiss | Mon, 06/10/2013 - 10:05
Gilead's drug will be one of the first to hit the market in a new generation of targeted hepatitis C treatments with high cure rates.
By Jonathan Weiss | Mon, 05/13/2013 - 10:21
With stunning results in Phase III clinical trials, the hepatitis C drug is now on a fast track for FDA approval.
By Nsikan Akpan | Tue, 05/07/2013 - 14:19
CDC finds half of Americans with Hepatitis C, mostly baby boomers, don’t follow up after initial screening and might require medical treatment.
By Jonathan Weiss | Fri, 04/26/2013 - 12:02
After a dentist in the Tulsa area was not properly sterilizing tools between patients, people are learning that they may have gotten more than a bill.